ABOUT KAYENTIS

Kayentis, a global leader in eCOA and Decentralized Clinical Trial solutions, empowers pharma, biotech, and CROs to streamline data collection in clinical trials, enhancing simplicity, efficiency, and data quality. Since 2005, Kayentis has spearheaded clinical development, specializing in eCOA solutions across phases I-IV in diverse therapeutic areas. Adapting to the changing landscape, Kayentis now offers a comprehensive suite of services to support the shift towards decentralized and hybrid trials, with operational capabilities across the USA, Europe, and Asia. 

Follow us on LinkedIn to discover new content every week!

kayentis.com

FEATURED ARTICLES

CONTACT INFORMATION

Kayentis

186 South Street Suite 600

Boston, MA 02111

UNITED STATES

Contact: Guillaume Juge, CEO

BROCHURES